Ronald G. Gill, PhD
Dr. Gill received his PhD in basic immunology at UCLA and performed a post-doctoral fellowship at the Barbara Davis Center for Childhood Diabetes. His first faculty position was at the University Of Colorado Health Sciences Center where he advanced to the rank of Professor of Medicine. In 2007 he was recruited to be the Scientific Director of the Alberta Diabetes Institute at the University of Alberta. He was later recruited back to the University of Colorado in 2010 to become the Scientific Director of the Colorado Center for Transplantation Care, Research, and Education (CCTCARE). He is currently Professor of Surgery and Immunology at the University of Colorado Denver.
Dr. Gill’s research program is focused on nature of immune-mediated injury and tolerance induction to tissue and organ transplants. His primary research activity has been in the area pancreatic islet transplantation as a treatment for insulin-dependent diabetes. He also has a strong interest in the nature of immune mediated acute and chronic rejection of vascularized transplants, especially cardiac allografts. He has published more that 130 research papers, reviews, and book chapters and received the 2012 AST Basic Scientist Established Investigator award.
Dr. Gill has served in a variety of roles for the American Society of Transplantation. He has been on the AST Board since 2013 and currently is the AST President. He has also served on other AST committees including the TIRN advisory committee and the Governance committee. He co-chaired the ATC Basic Science Abstract Committee in 2008-09 and is currently co-chair for the ATC program planning committee. He was a guest faculty/lecturer for the AST Fellows Symposium from 2011-2013. He has both organized and lectured at AST Guest Society Symposia at AAI. Prior, he chaired the AST Basic Science Advisory Committee in 2009 (currently the Community of Practice in Basic Science, COBS) and is the current COBS liaison. Finally, Dr. Gill has been an Associate Editor for the American Journal of Transplantation since 2005.
Dr. Gill has had a number of other responsibilities in the general areas of transplantation and autoimmunity. He has extensive grant review experience and has chaired two different NIH study sections in transplantation (TTT) and autoimmunity (IMS). He served seven years on the National Steering Committee of the Immune Tolerance Network has been on many other national committees in organizations such as the ITN, JDRF, NIDDK and others.
Updated June 2016